Rigicon has officially launched patient enrollment in the AUSOME Study (Artificial Urinary Sphincter Outcomes Multicenter Evaluation) in the UK, marking a significant milestone in its efforts to gain FDA Premarket Approval (PMA). The study evaluates the safety, effectiveness, and...
↧